US Stock Market Move | The empty market has temporarily paused. Avis Budget Group, Inc. (CAR.US) fell by more than 2%, after previously surging by 390% in the past month.
On Wednesday, the empty market trend of Anfistro (CAR.US) took a temporary break, with a morning high and then a drop, falling by more than 2% now after a cumulative surge of 390% earlier this month.
On Wednesday, Avis Budget Group, Inc. (CAR.US) experienced a pause in the short-selling frenzy, with the stock opening high and then falling back, now down over 2%, following a 390% surge earlier in the month. The trigger for this stock price surge for Avis Budget Group, Inc. was an epic "short squeeze" that began in early April. Pentwater Capital Management suddenly announced a large-scale position in Avis Budget Group, Inc., causing their stake to soar to 22%, combined with long-term major shareholder SRS Investment Management already holding nearly half of the shares, leading to a severe shortage of available tradable shares in the market.
Deutsche Bank Aktiengesellschaft analyst Chris Woronka stated, "We find it difficult to justify the current stock price using traditional indicators and a 12-month investment horizon." He downgraded Avis Budget Group, Inc.'s stock rating from "Buy" to "Hold." He added, "We believe that the risk of short squeezing causing further price increases still exists."
Related Articles

US Stock Market Move | Q1 performance exceeds expectations Intuitive Surgical, Inc. (ISRG.US) rose more than 8% in early trading.

JIANGSU EXPRESS (00177) plans to increase capital by 128 million yuan to Danjin Company.

SIMCERE PHARMA (02096): has voluntarily withdrawn the NDA for Ludechig Bai monoclonal antibody and is expected to resubmit the NDA later this month.
US Stock Market Move | Q1 performance exceeds expectations Intuitive Surgical, Inc. (ISRG.US) rose more than 8% in early trading.

JIANGSU EXPRESS (00177) plans to increase capital by 128 million yuan to Danjin Company.

SIMCERE PHARMA (02096): has voluntarily withdrawn the NDA for Ludechig Bai monoclonal antibody and is expected to resubmit the NDA later this month.

RECOMMEND

DeepSeek’s $10 Billion Valuation Financing Rumor And Four Layers Of Logical Judgment
21/04/2026

48 Hours Witness AI’s New Battlefield: Alibaba Joins, Tencent Open Sources, Manycore Tech Lists — Has The World Model Reached Its ChatGPT Moment?
21/04/2026

Public Fund Giants Reverse Course With Heavy Hong Kong IPO Cornerstone Allocations Exceeding HK$2.2 Billion Year‑To‑Date
21/04/2026


